Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Elinor Ben-Menachem

Professor, gäst

Elinor Ben-Menachem
Professor, gäst
elinor.ben-menachem@gu.se

Postal Address: Neurologen, Blå stråket 7, plan 0, 41345 Göteborg
Visiting Address: Neurologen, Blå stråket 7, plan 0, SU/Sahlgrenska sjukhuset , 41345 Göteborg


Department of Clinical Neuroscience at Institute of Neuroscience and Physiology (More Information)
Box 430
405 30 Göteborg
Visiting Address: Blå stråket 7, plan 3, Sahlgrenska , 413 45 Göteborg

Latest publications

Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data
A. Rohracher, G. Zimmermann, V. Villanueva, I. Garamendi, J. W. Sander et al.
Epilepsia, Journal article 2018
Journal article

Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate
B. E. Gidal, M. P. Jacobson, Elinor Ben-Menachem, M. Carreno, D. Blum et al.
Acta Neurologica Scandinavica, Journal article 2018
Journal article

Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs.
Scott Mintzer, Robert T Wechsler, Joanne B Rogin, Barry E Gidal, Matthias Schwab et al.
Epilepsy research, Journal article 2018
Journal article

Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures
E. Andermann, V. Biton, S. R. Benbadis, B. Shneker, A. K. Shah et al.
Epilepsy and Behavior, Journal article 2018
Journal article

Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies
Christian Elger, Mathias Koepp, Eugen Trinka, Vicente Villanueva, João Chaves et al.
CNS Neuroscience and Therapeutics, Journal article 2017
Journal article

Showing 1 - 10 of 92

2018

Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data
A. Rohracher, G. Zimmermann, V. Villanueva, I. Garamendi, J. W. Sander et al.
Epilepsia, Journal article 2018
Journal article

Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate
B. E. Gidal, M. P. Jacobson, Elinor Ben-Menachem, M. Carreno, D. Blum et al.
Acta Neurologica Scandinavica, Journal article 2018
Journal article

Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs.
Scott Mintzer, Robert T Wechsler, Joanne B Rogin, Barry E Gidal, Matthias Schwab et al.
Epilepsy research, Journal article 2018
Journal article

Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures
E. Andermann, V. Biton, S. R. Benbadis, B. Shneker, A. K. Shah et al.
Epilepsy and Behavior, Journal article 2018
Journal article

2017

Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies
Christian Elger, Mathias Koepp, Eugen Trinka, Vicente Villanueva, João Chaves et al.
CNS Neuroscience and Therapeutics, Journal article 2017
Journal article

Showing 1 - 10 of 92

Page Manager: Katinka Almrén|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?